Tilray Brands, Inc.

NASDAQ:TLRY

1.62 (USD) • At close September 6, 2024
Bedrijfsnaam Tilray Brands, Inc.
Symbool TLRY
Munteenheid USD
Prijs 1.62
Beurswaarde 1,365,598,440
Dividendpercentage 0%
52-weken bereik 1.5 - 3.37
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Irwin David Simon
Website https://www.tilray.com

An error occurred while fetching data.

Over Tilray Brands, Inc.

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use

Vergelijkbare Aandelen

Arvinas, Inc. logo

Arvinas, Inc.

ARVN

24.4 USD

PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc.

PTCT

31.54 USD

Beam Therapeutics Inc. logo

Beam Therapeutics Inc.

BEAM

23.31 USD

Corcept Therapeutics Incorporated logo

Corcept Therapeutics Incorporated

CORT

34.38 USD

AbCellera Biologics Inc. logo

AbCellera Biologics Inc.

ABCL

2.39 USD

Fate Therapeutics, Inc. logo

Fate Therapeutics, Inc.

FATE

3.39 USD

EQRx, Inc. logo

EQRx, Inc.

EQRX

2.34 USD

Iovance Biotherapeutics, Inc. logo

Iovance Biotherapeutics, Inc.

IOVA

10.01 USD

Canopy Growth Corporation logo

Canopy Growth Corporation

CGC

4.48 USD

Amicus Therapeutics, Inc. logo

Amicus Therapeutics, Inc.

FOLD

11.65 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)